BioSpace News Archive

ReCode Therapeutics today announced the appointment of Angèle Maki, Ph.D., as senior vice president, business development.

Halberd Corporation’s research at Youngstown State University caught the attention of Youngstown, OH TV news station, WKBN, a CBS affiliate.

9 Meters Biopharma, Inc., a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases by studying unique GI biology, announced a collaboration with the European Biomedical Research Institute of Salerno, Italy to study larazotide for the treatment of multisystem inflammatory syndrome in children.

Lantern Pharma (NASDAQ: LTRN), today announced that Lantern Pharma’s abstract titled ‘LP-184, a novel alkylating agent, is highly effective in pancreatic cancers with DNA damage repair defects’ has been accepted as a virtual poster at the upcoming AACR Virtual Special Conference on Pancreatic Cancer being held on September 29-30, 2021.

Oramed Pharmaceuticals Inc. today announced that Diabetes, Obesity, and Metabolism, has published an original article titled “Efficacy and safety of 28-day treatment with oral insulin (ORMD-0801) in patients with type 2 diabetes mellitus

The over-the-counter pain medication market is predicted to display notable growth over the forecast period from 2020 to 2030.

Rapid prototyping (RP) is one of the applications of rapid manufacturing and a type of computer-aided technology that is capable of making physical objects directly from three-dimensional (3D) computer data by adding a layer-upon-layer

Lebrikizumab led to significant improvements with at least 75 percent skin clearance in more than half of people with moderate-to-severe atopic dermatitis, as measured by EASI, in Eli Lilly and Company’s ADvocate 1 and ADvocate 2 Phase 3 clinical trials.

Medivir AB announced that Medivir AB together with the originators of remetinostat, and TetraLogic Pharmaceuticals Corporation and The Leukemia & Lymphoma Society have restructured and streamlined the financial obligations for remetinostat, a topical histone deacetylase inhibitor, for the treatment of cutaneous T-cell lymphoma and potentially other types of skin cancers.

Biotage is one of the few companies offering a complete solution and ready to go, off-the-shelf products for the purification of large scale lipids, used in mRNA vaccine development and production.